Bakker Juliet Tammenoms - 17 Jun 2026 Form 4 Insider Report for RxSight, Inc. (RXST)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Jun 2026, 16:06:50 UTC
Prior SEC filing
04 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jim Schindler, as Attorney-in-Fact

Key filing fact

Bakker Juliet Tammenoms filed Form 4 for RxSight, Inc. (RXST) on 18 Jun 2026.

Key facts

  • This page summarizes Bakker Juliet Tammenoms's Form 4 filing for RxSight, Inc. (RXST).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Jun 2026, 16:06.

Change

  • Previous filing in this sequence was filed on 04 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001431159 Primary reporting owner

Tammenoms Bakker Juliet

Relationship
Director
Address
C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO
Signature
/s/ Jim Schindler, as Attorney-in-Fact
Signature date
18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXST transaction

Common Stock

Award

Transaction value
Shares
+37,037
Change %
+77%
Price
Shares after
85,183
Date
17 Jun 2026
Ownership
Direct
Footnotes
F1, F2
RXST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,548
Date
17 Jun 2026
Ownership
See footnote
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.

Footnote F2

Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Footnote F3

These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .